Viewing Study NCT00388960


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-27 @ 5:31 AM
Study NCT ID: NCT00388960
Status: COMPLETED
Last Update Posted: 2019-11-19
First Post: 2006-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module